Please assess the completion status of the following clinical trial:

Trial Title: Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* hypertension with left ventricular hypertrophy~Exclusion Criteria:~* clinical or laboratory evidence of secondary hypertension~* heart failure~* ischemic heart disease~* valvular heart disease~* arrhythmias~* peripheral vascular disease~* chronic obstructive pulmonary disease~* neurologic disorders~* diabetes mellitus~* renal dysfunction~* notable systemic disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Valsartan treatment (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).